Holen Sie sich die Stockscreener-App
0.4735
4.15%
-0.0205
Handel nachbörslich:
.49
0.0165
+3.48%
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harvard Bioscience: Q4 Earnings Snapshot - Chron
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria
Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada
Harvard Bioscience Q4 & Annual Financial Results 2025News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com
HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus
Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus
HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus
Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget
Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView
HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Harvard Bioscience promotes Frost to CFO - Worcester Business Journal
Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart
Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks
Harvard Bioscience Announces Reverse Stock Split - 富途牛牛
Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq
Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com
Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn
Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks
Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative
Harvard Bioscience announces reverse stock split - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Harvard Bioscience to turn 10 shares into 1 in March split - Stock Titan
Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill
Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru
Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru
Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru
HBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HBIO Should I Buy - Intellectia AI
Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru
Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru
Harvard Bioscience reports Q4 revenue in line with guidance - Investing.com South Africa
HBIO Posts Strong Q4 Results with Positive Outlook for Future Gr - GuruFocus
Harvard Bioscience reports Q4 revenue in line with guidance By Investing.com - Investing.com Nigeria
Returns Recap: Will Harvard Bioscience Inc face regulatory challengesJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
Harvard Bioscience (HBIO) Faces Strategic Evolution in Life Scie - GuruFocus
Harvard Bioscience Reports Strong Q4 Results and Growth Strategy - Intellectia AI
Harvard Bioscience Reports Preliminary Q4 Results and Outlines Growth Strategy for 2026 - Quiver Quantitative
0.97%
1.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):